Crispr Therapeutics shares tumble after significant earnings miss
SEMrush Holdings, Inc. (NASDAQ:SEMR) recently reported a stock transaction involving its Chief Marketing Officer, Andrew Warden. According to the SEC filing, Warden sold 17,118 shares of SEMrush Class A common stock on March 3, 2025. The shares were sold at a weighted average price of $11.20, resulting in a total transaction value of $191,721. The transaction comes as SEMrush, currently valued at $1.6 billion, trades near its 52-week low of $10.15, having declined nearly 29% in the past week.
The sale was part of a process to meet tax withholding obligations following the vesting of restricted stock units (RSUs) on March 1, 2025, and was not a discretionary trade by Warden. Following this transaction, Warden holds 404,992 shares, which include a portion of RSUs that will vest over the coming years.
Additionally, on March 1, 2025, Warden acquired 145,454 shares through a grant of RSUs under SEMrush’s 2021 Stock Option and Incentive Plan. These RSUs will vest over a three-year period, beginning on March 1, 2026, with subsequent quarterly installments.
In other recent news, Semrush Holdings Inc. reported its fourth-quarter 2024 earnings with revenue reaching $102.6 million, exceeding the forecast of $101.03 million and showing a 23% year-over-year growth. However, the company missed its earnings per share (EPS) forecast, reporting $0.02 against an expected $0.06. For the full year, Semrush achieved a revenue of $376.8 million, marking a 22% increase from 2023. Despite the revenue growth, the company faced challenges in maintaining profitability, as reflected in the EPS miss. In response to these results, Semrush is focusing on expanding its AI capabilities and enterprise offerings to drive future growth. The company projects Q1 2025 revenue between $103.9 million and $104.7 million, indicating a 22% year-over-year growth. Analyst feedback from firms like JPMorgan highlighted concerns about market competition and economic conditions, which the company aims to address through innovation and strategic expansion. Additionally, Semrush’s leadership transition sees Bill Wagner stepping in as CEO, with outgoing CEO Oleg Shlagle transitioning to the role of Chief Technology Officer.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.